Skip to main content
. 2019 Aug 1;9(8):e027940. doi: 10.1136/bmjopen-2018-027940

Figure 2.

Figure 2

Risk of anti-tuberculosis drug-induced liver injury in patients with the CYP2E1 (A) RsaI/PstI c1/c1 genotype compared with c1/c2+c2/c2 genotypes and (B) DraI D/D genotype compared with D/C+C/C genotypes. CYP2E1, cytochrome P450 2E1.